Fred Alger Management »

Terns Pharmaceuticals shares owned by Fred Alger Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 90k 40.40
2023-03-31 $193k 16k 11.84

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Meta Platforms Inc Class A Equity (META)
Apple Equity (AAPL)
AppLovin Corp. Class A Equity (APP)
Alphabet Inc. Class C Equity (GOOG)
Broadcom Equity (AVGO)
Tesla Equity (TSLA)
Talen Energy Corp Equity (TLN)
Nebius Group N.V. Class A Equity (NBIS)
Western Digital Corporation Equity (WDC)
Natera Equity (NTRA)
Sea Limited Sponsored ADR Class A Equity (SE)
Astera Labs Equity (ALAB)

View all positions for Fred Alger Management

Top funds holding Terns Pharmaceuticals

BlackRock
Adage Capital Partners GP
Vanguard Group
Vivo Capital
Vestal Point Capital
venBio Select Advisor
Citadel Advisors
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
OrbiMed Advisors
Geode Capital Management
Ameriprise Financial
State Street Corporation
Acorn Capital Advisors

View all funds holding Terns Pharmaceuticals